Literature DB >> 9269705

Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control.

A E Alaveras1, S M Thomas, A Sagriotis, G C Viberti.   

Abstract

BACKGROUND AND AIMS: Hyperglycaemia is a strong risk factor for the development of renal disease in insulin dependent diabetes mellitus but it is uncertain whether it contributes to the progression of incipient or established nephropathy. The rigorous treatment of blood pressure in recent years may help uncover the contribution of hyperglycaemia, if any, to the progression of renal failure. Our aim therefore, was to assess in a current cohort of insulin dependent diabetic patients with diabetic nephropathy the relative importance of glycaemic control and blood pressure on disease progression.
METHODS: All insulin dependent diabetic patients with persistent albuminuria (> 300 mg/24 h) attending the diabetic clinic at Guy's Hospital between 1977 and 1993 were recruited. Serial measurements of blood pressure, HbA1 and GFR were performed every 6 months until end-stage renal disease or death. Only patients with at least 1 year of follow up were analysed. The mean follow up period was 8 years (range 1.5-15.5 years). Baseline and time dependent variables were related to the rate of change of GFR using weighted linear regression and stepwise multiple regression analysis. The impact of each variable on the change of GFR with time was adjusted for the effect of other potentially confounding variables by analysis of co-variance.
RESULTS: Patients had well-controlled blood pressure throughout the observation period (mean arterial pressure 97 +/- 8 mmHg) and the average rate of decline of GFR was 4.32 +/- 4.08 ml/min/year. In univariate analysis baseline and mean HbA1 were linearly related to the rate of decline of GFR (baseline r5-0.565, P < 0.001; mean r-0.5107, P < 0.001) with those with a higher HbA1 having a faster rate of progression. In stepwise multivariate analysis both mean HbA1 mean diastolic blood pressure (P < 0.0001 and P = 0.019, respectively) was significantly and independently related with a faster rate of decline of GFR.
CONCLUSIONS: Worse glycaemic control is associated with a faster rate of progression of diabetic nephropathy once blood pressure is controlled. Thus improvement of glycaemic control in patients where good blood pressure control has been achieved may potentially further delay the progression of nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269705

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

Authors:  Jan Skupien; James H Warram; Adam Smiles; Andrzej Galecki; Robert C Stanton; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

Review 2.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop.

Authors:  Donald Fraser; Nigel Brunskill; Takafumi Ito; Aled Phillips
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 4.  The role of renal proximal tubular cells in diabetic nephropathy.

Authors:  Aled O Phillips
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

5.  Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.

Authors:  Sung-Hsun Yu; Navneet Kumar Dubey; Wei-Shan Li; Ming-Che Liu; Han-Sun Chiang; Sy-Jye Leu; Ying-Hua Shieh; Feng-Chou Tsai; Win-Ping Deng
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 6.  Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease.

Authors:  Chaudhary Muhammad Junaid Nazar
Journal:  J Nephropharmacol       Date:  2014-01-01

7.  Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study.

Authors:  Hongyang Jiang; Yan Zhang; Dongyan Xu; Qing Wang
Journal:  J Clin Lab Anal       Date:  2021-03-05       Impact factor: 2.352

8.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

Review 9.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Klaus Jeitler; Mirjam Seitz; Karl Horvath; Andrea Berghold; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14

10.  Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.

Authors:  Anna Czajka; Saima Ajaz; Luigi Gnudi; Chandani Kiran Parsade; Peter Jones; Fiona Reid; Afshan N Malik
Journal:  EBioMedicine       Date:  2015-04-11       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.